-
Review
January 5, 2023
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
- Clin Mol Hepatol. 2023;29(2):197-205.
Articles in E-pub version are posted online ahead of regular printed publication.
- Review
- The Evolving Role of Lenvatinib at the New Era of First-Line HCC Treatment
- Landon L. Chan, Stephen L. Chan
- Received March 22, 2023 Accepted May 25, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0114 [Accepted]
-
View: 89 Download: 10
- Letter to the Editor
- Assessing the performance of ChatGPT: Comment
- Amnuay Kleebayoon, Viroj Wiwanitkit
- Received May 18, 2023 Accepted May 23, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0170 [Accepted]
-
View: 74 Download: 11
- Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
- Joo Hyun Oh, Dong Hyun Sinn
- Received April 4, 2023 Accepted April 5, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0135 [Accepted]
-
View: 81 Download: 5
- Letter regarding “Examining the Accuracy and Reproducibility of ChatGPT in Answering Questions on Cirrhosis and Hepatocellular Carcinoma Management”
- Hassam Ali
- Received March 26, 2023 Accepted March 27, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0120 [Accepted]
-
View: 160 Download: 22
- Non-alcoholic fatty liver disease: Definition and subtypes: Is time to change the concept from liver disease to systemic disease?
- Seul Ki Han, Soon Koo Baik, Moon Young Kim
- Received April 25, 2023 Accepted May 15, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0155 [Accepted]
-
View: 120 Download: 11
- Original Article
- Treated Chronic Hepatitis B Is a Good Prognostic Factor of Diffuse Large B-Cell Lymphoma
- Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
- Received February 13, 2023 Accepted May 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0057 [Accepted]
-
View: 167 Download: 19
- Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
- Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim
- Received March 16, 2023 Accepted May 12, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0110 [Accepted]
-
View: 120 Download: 14
- HCC prediction model performance decrease with long-term antiviral therapy in chronic hepatitis B patients
- Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, YaMeng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You
- Received March 27, 2023 Accepted May 10, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0121 [Accepted]
-
View: 193 Download: 21
- Letter to the Editor
- The upper limit of normal for ALT in males according to AASLD guideline
- Halil Haldun Emiroglu
- Received March 30, 2023 Accepted April 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0132 [Accepted]
-
View: 113 Download: 1
- Subtypes of non-alcoholic fatty liver disease in terms of cardiovascular disease and dementia risks
- Seogsong Jeong, Yohwan Lim, Su Kyoung Lee, Hyun Wook Han
- Received March 29, 2023 Accepted April 5, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0129 [Accepted]
-
View: 153 Download: 16
- Original Article
- Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and MR imaging
- Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim
- Received January 29, 2023 Accepted May 6, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0034 [Accepted]
-
View: 214 Download: 24
- Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
- Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-Sun Wong, Ming-Whei Yu, Mindie H. Nguyen
- Received January 5, 2023 Accepted April 29, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0004 [Accepted]
-
View: 397 Download: 41
- Review
- KASL Clinical Practice Guidelines for Management of Autoimmune Hepatitis 2022
- Received March 1, 2023 Accepted April 3, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0087 [Accepted]
-
View: 194 Download: 39
- Hepatorenal Syndrome: Current Concepts and Future Perspectives
- Chan-Young Jung, Jai Won Chang
- Received January 25, 2023 Accepted April 10, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0024 [Accepted]
-
View: 1826 Download: 711
- Original Article
- Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Received March 3, 2023 Accepted March 21, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0089 [Accepted]
-
View: 4668 Download: 758 Citations: 3
- Review
- Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
- Vinay Kumar BR, Shiv Kumar Sarin
- Received April 16, 2022 Accepted February 25, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0103 [Accepted]
-
View: 864 Download: 224
- Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
- Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
- Received November 26, 2022 Accepted March 13, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0420 [Accepted]
-
View: 457 Download: 51
- Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- Received December 2, 2022 Accepted March 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0434 [Accepted]
-
View: 569 Download: 104 Citation: 1
- Original Article
- Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
- Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
- Received October 22, 2022 Accepted March 6, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0330 [Accepted]
-
View: 461 Download: 45
- Review
- A decade of liver organoids: Advancements in disease modeling
- Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
- Received November 29, 2022 Accepted February 28, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0428 [Accepted]
-
View: 3169 Download: 114
- Acute hepatitis C virus infection: clinical update and remaining challenges
- Chen-Hua Liu, Jia-Horng Kao
- Received October 30, 2022 Accepted February 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0349 [Accepted]
-
View: 767 Download: 174 Citations: 2
- Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
- Chih-Lin Lin, Jia-Horng Kao
- Received October 31, 2022 Accepted February 12, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0342 [Epub ahead of print]
-
View: 691 Download: 132
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
- Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
- Received November 9, 2022 Accepted February 9, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0391 [Epub ahead of print]
-
View: 710 Download: 141 Citations: 2
